|
2021
|
Invention
|
Pharmaceutical compositions and methods targeting wnt pathway proteins. Provided is a composition... |
|
|
Invention
|
Glucocerebroside treatment of disease.
The present invention provides a method for the treatment... |
|
|
Invention
|
Sphingosine kinase type 1 inhibitors and uses thereof. Provided are inhibitors of sphingosine kin... |
|
2020
|
Invention
|
Methods for treating psoriasis.
The present invention relates to methods for treating psoriasis ... |
|
2019
|
Invention
|
Methods for treating psoriasis. The present invention relates to methods for treating psoriasis a... |
|
|
Invention
|
Methods for treating bone loss using sclerostin peptides. Provided is a composition comprising a ... |
|
2018
|
Invention
|
Glucocerebroside treatment of disease. The present invention provides a method for the treatment ... |
|
2017
|
Invention
|
Method for treating hiv.
The present invention provides novel processes for regulating immune re... |
|
|
Invention
|
Methods for treating melanoma.
The present invention relates to methods for treating melanoma an... |
|
|
Invention
|
Glucocerebroside treatment of liver disorders. The present invention provides a method for the tr... |
|
2016
|
Invention
|
Leptin in immune modulation.
The present invention relates to methods for treating inflammatory ... |
|
|
Invention
|
Pharmaceutical compositions targeting wnt pathway proteins. Provided is a composition comprising ... |
|
2015
|
Invention
|
Methods for modulating th1/th2 cell balance by increasing leptin activity. The present invention ... |
|
2012
|
Invention
|
Sphingosine kinase type 1 inhibitors. Provided are novel compositions and analogs which are usefu... |
|
2010
|
Invention
|
Sclerostin and the inhibition of wnt signaling and bone formation.
The loss of the SOST gene pr... |
|
|
Invention
|
Methods for decreasing leptin levels or activity for treating inflammation. The present invention... |
|
|
Invention
|
Sphingosine type 1 inhibitors and methods for making and using same. Provided are novel compositi... |
|
|
Invention
|
Novel sphingosine kinase type 1 inhibitors, compositions and processes for using same. Provided a... |
|
2009
|
Invention
|
Synthetic derivatives beta glycolipids and compositions thereof for the treatment of pathologic d... |
|
|
Invention
|
Synthetic glycolipid analogues and derivatives for the treatment of pathologic disorders. The pre... |
|
|
Invention
|
Sphingosine kinase type 1 inhibitors, and processes for using same. Provided are novel compositio... |
|
|
Invention
|
Sphingosine kinase type 1 inhibitors, compositions and processes for using same. Provided are nov... |
|
2008
|
Invention
|
Cell line for producing a non-retroviral vector.
Provided are novel vectors and viral vectors ca... |
|
2007
|
Invention
|
Composition of matter comprising primary nucleic acid component.
The present invention provides ... |
|
2006
|
Invention
|
Compositions and methods for bone formation and remodeling. The mechanism by which the high bone ... |
|
|
Invention
|
Antibodies against april as biomarkers for early prognosis of lymphoma patients. The invention re... |
|
2005
|
Invention
|
Β glycolipids as immuno-modulators. The invention relates to the use of β-glycolipids as immunomo... |
|
|
Invention
|
Vectors for expressing exogenous gene or exogenous nucleic acid sequences.
Provided are novel ve... |
|
|
Invention
|
viral vectors with surface or envelope components.
Provided are novel vectors and viral vectors... |
|
|
Invention
|
Compositions and methods for bone formation and remodeling. The mechanism by which the high... |
|
2004
|
Invention
|
Methods and uses of leptin in immune modulation. The present invention describes the use of lepti... |
|
|
Invention
|
Methods and uses of leptin in hepatocellular carcinoma. The present invention relates to methods ... |
|
2003
|
Invention
|
Novel therapeutic processes for treating infectious agents using same epitope specific antigens, ... |
|
1998
|
Invention
|
Retroviral vectors expressing exogenous gene or exogenous nucleic acid sequences. Provided are no... |
|
|
Invention
|
Independent helper virus packaging cell line for propagating viral vectors. Provided are novel ve... |
|
|
Invention
|
Biological function effecting viral vectors and chimeric cells useful as packaging cell lines and... |
|
1995
|
Invention
|
Method for in vivo delivery of active compounds using reagent conjugate. This invention relates t... |
